Robert Q. Le
- Oncology top 10%
- Infectious Diseases top 10%
- Neurology top 10%
- Immunology
- Hematology top 10%
- Co-authors
- Donna PrzepiorkaRichard PazdurWeishi YuanAnn T. FarrellStacy S. ShordBahru HabtemariamLiang LiLei Nie
- Topics
- Hematopoietic Stem Cell Transplantation (7 papers)Acute Myeloid Leukemia Research (6 papers)CAR-T cell therapy research (5 papers)
- Journals
- SHILAP Revista de lepidopterologíaBloodClinical Cancer Research
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Robert Q. Le
15 papers receiving 740 citations
Hit Papers
Peers
Comparison fields: 5 of 80
- Oncology 397
- Infectious Diseases 216
- Neurology 163
- Immunology 162
- Hematology 131
Countries citing papers authored by Robert Q. Le
This map shows the geographic impact of Robert Q. Le's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Q. Le with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Q. Le more than expected).
Fields of papers citing papers by Robert Q. Le
This network shows the impact of papers produced by Robert Q. Le. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Q. Le. The network helps show where Robert Q. Le may publish in the future.
Co-authorship network of co-authors of Robert Q. Le
This figure shows the co-authorship network connecting the top 25 collaborators of Robert Q. Le. A scholar is included among the top collaborators of Robert Q. Le based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Q. Le. Robert Q. Le is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 6 | |
| 3 | 17 | |
| 4 | 4 | |
| 5 | FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndromebreakdown → | 610 |
| 6 | 7 | |
| 7 | 2 | |
| 8 | 9 | |
| 9 | 29 | |
| 10 | 5 | |
| 11 | 1 | |
| 12 | 15 | |
| 13 | 1 | |
| 14 | 13 | |
| 15 | 12 | |
| 16 | 24 |
About Robert Q. Le
Robert Q. Le is a scholar working on Hematology, Transplantation and Oncology, having authored 16 papers that have together received 755 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (7 papers), Acute Myeloid Leukemia Research (6 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Oncology (397 citations), Hematology (131 citations) and Infectious Diseases (216 citations). Robert Q. Le has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Donna Przepiorka, Richard Pazdur, Weishi Yuan, Ann T. Farrell, Stacy S. Shord, Bahru Habtemariam, Liang Li, Lei Nie, Bipin N. Savani and A. John Barrett. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.